STOCK TITAN

Eli Lilly (NYSE: LLY) director adds to stake with deferred stock units

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ELI LILLY & Co (LLY) director Ralph Alvarez reported an acquisition of common stock as compensation. On 2026-08-17, he received 10.4945 shares valued at $1183.16 per share, granted as deferred stock units under the Lilly Directors' Deferral Plan, to be settled in shares after he leaves board service. Following this, he holds 55,744.788 shares directly and 758 shares indirectly through a trust, for which he disclaims beneficial ownership beyond his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Alvarez Ralph
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 10.4945 $1,183.16 $12K
holding Common Stock F2 -- -- --
Holdings After Transaction: Common Stock — 55,744.788 shares (Direct); Common Stock — 758 shares (Indirect, By Trust)
Footnotes (2)
  1. F1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
  2. F2. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Shares granted 10.4945 shares Common stock award on 2026-08-17 under Lilly Directors' Deferral Plan
Grant value per share $1183.16 per share Value used for the 10.4945-share deferred compensation award
Direct holdings after transaction 55,744.788 shares Direct Eli Lilly common stock owned by Ralph Alvarez after the award
Indirect holdings by trust 758 shares Shares held indirectly through a trust, with beneficial ownership disclaimed in part
Lilly Directors' Deferral Plan financial
"shares acquired have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan"
stock units financial
"deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan"
Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest"

FAQ

What insider transaction did LLY director Ralph Alvarez report on August 17, 2026?

Ralph Alvarez reported a grant of 10.4945 shares of Eli Lilly common stock on 2026-08-17. The shares were awarded as deferred stock units under the Lilly Directors' Deferral Plan and will be settled in common stock after his separation from board service.

Was Ralph Alvarez’s August 2026 LLY stock transaction a market purchase or sale?

The August 2026 transaction was a grant/award acquisition, not a market purchase or sale. The 10.4945 shares represent deferred stock units received in lieu of cash compensation under the Lilly Directors' Deferral Plan, to be settled later in common stock.

How many LLY shares does Ralph Alvarez hold directly after this Form 4 transaction?

After the reported grant, Ralph Alvarez directly holds 55,744.788 shares of Eli Lilly common stock. This figure reflects his direct ownership position following the 10.4945-share deferred compensation award reported on 2026-08-17.

What is the reported price per share for Ralph Alvarez’s LLY stock grant?

The reported value for the grant is $1183.16 per share of Eli Lilly common stock. This price is used to value the 10.4945 shares awarded as deferred stock units under the Lilly Directors' Deferral Plan on 2026-08-17.

What indirect LLY holdings does Ralph Alvarez report in this Form 4?

Ralph Alvarez reports 758 Eli Lilly shares held indirectly "By Trust". He disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, indicating they are held through a trust arrangement rather than in his direct name.

How will the deferred stock units reported by Ralph Alvarez in LLY be settled?

The deferred stock units will be settled in Eli Lilly common stock after Alvarez’s separation from service as a director. He elected to defer this compensation as stock units under the Lilly Directors' Deferral Plan instead of receiving cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Alvarez Ralph

(Last)(First)(Middle)
LILLY CORPORATE CENTER

(Street)
INDIANAPOLIS INDIANA 46285

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/17/2026A10.4945(1)A$1,183.1655,744.788D
Common Stock758IBy Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
2. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Remarks:
/s/ Jonathan Groff for Ralph Alvarez, pursuant to authorization on file08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)